Articles

Fundstrat Global Advisors, Tom Lee, makes a bet on a post-Fed rally, offering five reasons for that and stocks he thinks investors should hold onto.

BioNTech’s stock sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below expectations, weighed down by inventory writedowns by COVID-19 vaccine collaboration partner Pfizer.

Citigroup cuts Wells Fargo rating to neutral on ‘balanced’ risk/reward but boosts price target

Labor Department’s fiduciary rule runs counter to the life insurance industry’s practices.

Mortgage applications fell 1.6% in the last week, the Mortgage Bankers Association said. The average rate for a 30-year mortgage is 6.97%.

The Department of Commerce struck a preliminary deal with Intel that will provide the company with up to $8.5 billion in direct funding and $11 billion in loans through the Chips Act.

Oil futures pull back as traders await inventory data and the outcome of a Federal Reserve policy meeting.

“I owe $280,000 after using the equity and simultaneously having my equity used up by unscrupulous mortgage companies.”

Cook’s visit comes ahead of the opening of a new Apple store in central Shanghai on Thurdsay

Boeing’s CFO said cash flow will be worse than the company had expected even back in January as the troubled plane maker focuses on quality after a spate of incidents.

The number of Americans aged 100 and older is projected to surge over the next 30 years.

As Alzheimer’s disease claims the lives of increasing numbers of people in the U.S., detection and diagnosis of the condition aren’t keeping pace with the challenge, a new report shows.